{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:14:31Z","timestamp":1788869671209,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":3935,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo \u2013 FAPESP"},{"name":"Conselho Nacional de Pesquisa"},{"DOI":"10.13039\/501100002322","name":"Capes","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.imbio.2012.07.032","type":"journal-article","created":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T10:45:53Z","timestamp":1344336353000},"page":"609-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["B16 melanoma cells increase B-1 cell survival, IL-10 production and radioresistance in vitro"],"prefix":"10.1016","volume":"218","author":[{"given":"Maria Fernanda Lucatelli","family":"Laurindo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Garutti","family":"Thies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Cristina","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronni R\u00f4mulo","family":"Novaes e Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Mariano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Flavia","family":"Popi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.imbio.2012.07.032_bib0005","first-page":"5137","volume":"61","author":"Alas","year":"2001","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.imbio.2012.07.032_bib0010","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/intimm\/13.9.1193","article-title":"Mouse B-1 cell-derived mononuclear phagocyte, a novel cellular component of acute non-specific inflammatory exudate","volume":"13","author":"Almeida","year":"2001","journal-title":"Int. Immunol."},{"issue":"9255","key":"10.1016\/j.imbio.2012.07.032_bib0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.imbio.2012.07.032_bib0020","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.4049\/jimmunol.165.3.1612","article-title":"Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression","volume":"165","author":"Benkhart","year":"2000","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2012.07.032_bib0025","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ijc.2910390324","article-title":"A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth","volume":"39","author":"Bennett","year":"1987","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.imbio.2012.07.032_bib0030","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.4049\/jimmunol.155.9.4155","article-title":"Fibroblasts support outgrowth of splenocytes simultaneously expressing B lymphocyte and macrophage characteristics","volume":"155","author":"Borrello","year":"1995","journal-title":"J. Immunol."},{"issue":"20","key":"10.1016\/j.imbio.2012.07.032_bib0035","first-page":"4633","article-title":"Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines","volume":"55","author":"Borsellino","year":"1995","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.imbio.2012.07.032_bib0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccr.2005.04.014","article-title":"De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent","volume":"7","author":"de Visser","year":"2005","journal-title":"Cancer Cell"},{"issue":"35","key":"10.1016\/j.imbio.2012.07.032_bib0045","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1200\/JCO.2005.10.007","article-title":"Global role of the immune system in identifying cancer initiation and limiting disease progression","volume":"23","author":"Disis","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.imbio.2012.07.032_bib0050","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.146.10.3444","article-title":"IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells","volume":"146","author":"Fiorentino","year":"1991","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.imbio.2012.07.032_bib0055","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1073\/pnas.0712350105","article-title":"CD11b expression distinguishes sequential stages of peritoneal B-1 development","volume":"105","author":"Ghosn","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.imbio.2012.07.032_bib0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.imbio.2012.07.032_bib0065","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1182\/blood.V88.10.3972.bloodjournal88103972","article-title":"Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop","volume":"88","author":"Gu","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.imbio.2012.07.032_bib0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.imbio.2012.07.032_bib0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1084\/jem.157.1.202","article-title":"The \u201cLy-1 B\u201d cell subpopulation in normal immunodefective, and autoimmune mice","volume":"157","author":"Hayakawa","year":"1983","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2012.07.032_bib0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-065X.1986.tb01503.x","article-title":"The Ly-1 B cell lineage","volume":"93","author":"Herzenberg","year":"1986","journal-title":"Immunol. Rev."},{"issue":"15","key":"10.1016\/j.imbio.2012.07.032_bib0085","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1158\/0008-5472.CAN-05-3766","article-title":"Inhibitory effects of B cells on antitumor immunity","volume":"66","author":"Inoue","year":"2006","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.imbio.2012.07.032_bib0090","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.175.5.1213","article-title":"Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells","volume":"175","author":"Ishida","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2012.07.032_bib0095","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.iy.11.040193.002441","article-title":"Origin of murine B cell lineages","volume":"11","author":"Kantor","year":"1993","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2012.07.032_bib0100","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1084\/jem.185.6.1035","article-title":"Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes","volume":"185","author":"Karras","year":"1997","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.imbio.2012.07.032_bib0105","first-page":"1169","article-title":"Change of mouse CD5(+) B1 cells to a macrophage-like morphology induced by gamma interferon and inhibited by interleukin-4","volume":"9","author":"Koide","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"5","key":"10.1016\/j.imbio.2012.07.032_bib0110","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.0803773","article-title":"In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy","volume":"183","author":"Li","year":"2009","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.imbio.2012.07.032_bib0115","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1172\/JCI31537","article-title":"A cytokine-mediated link between innate immunity, inflammation, and cancer","volume":"117","author":"Lin","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.imbio.2012.07.032_bib0120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.imbio.2012.07.032_bib0125","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/cgt.2010.58","article-title":"Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-gamma-dependent response against B16F10-Nex2 melanoma","volume":"18","author":"Marchi","year":"2011","journal-title":"Cancer Gene Ther."},{"issue":"6","key":"10.1016\/j.imbio.2012.07.032_bib0130","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1084\/jem.180.6.2371","article-title":"Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression","volume":"180","author":"Matsuda","year":"1994","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.imbio.2012.07.032_bib0135","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0022-5347(17)35347-8","article-title":"Overcoming TNF-alpha and drug resistance of human renal cell carcinoma cells by treatment with pentoxifylline in combination with TNF-alpha or drugs: the role of TNF-alpha mRNA downregulation in tumor cell sensitization","volume":"151","author":"Mizutani","year":"1994","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.imbio.2012.07.032_bib0140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1081\/CNV-100102550","article-title":"Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma","volume":"19","author":"Nemunaitis","year":"2001","journal-title":"Cancer Invest."},{"issue":"3","key":"10.1016\/j.imbio.2012.07.032_bib0145","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/eji.1830220314","article-title":"Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10","volume":"22","author":"O\u2019Garra","year":"1992","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2012.07.032_bib0150","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.imbio.2009.03.009","article-title":"B-1 cells modulate the kinetics of wound-healing process in mice","volume":"215","author":"Oliveira","year":"2010","journal-title":"Immunobiology"},{"issue":"10","key":"10.1016\/j.imbio.2012.07.032_bib0155","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.4049\/jimmunol.177.10.6593","article-title":"Cutting edge: inherent and acquired resistance to radiation-induced apoptosis in B cells: a pivotal role for STAT3","volume":"177","author":"Otero","year":"2006","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.imbio.2012.07.032_bib0160","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1349-7006.2008.00776.x","article-title":"B-1 lymphocytes increase metastatic behavior of melanoma cells through the extracellular signal-regulated kinase pathway","volume":"99","author":"Perez","year":"2008","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.imbio.2012.07.032_bib0165","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.4049\/jimmunol.161.5.2099","article-title":"Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1\/2 function in the prototype NK target YAC-1","volume":"161","author":"Petersson","year":"1998","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2012.07.032_bib0170","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2567.2004.01969.x","article-title":"Interleukin-10 secreted by B-1 cells modulates the phagocytic activity of murine macrophages in vitro","volume":"113","author":"Popi","year":"2004","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.imbio.2012.07.032_bib0230","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2567.2008.02883.x","article-title":"Co-ordinated expression of lymphoid and myeloid specific transcription factors during B-1b cell differentiation into mononuclear phagocytes in vitro","volume":"126","author":"Popi","year":"2009","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.imbio.2012.07.032_bib0175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.imbio.2012.07.032_bib0180","first-page":"1383","article-title":"Interleukin 10 production by human melanoma","volume":"2","author":"Sato","year":"1996","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.imbio.2012.07.032_bib0185","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ijc.21177","article-title":"Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells","volume":"117","author":"Shah","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.imbio.2012.07.032_bib0190","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1158\/0008-5472.CAN-03-3179","article-title":"Ammonium trichloro(dioxoethylene-o,o\u2032)tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop","volume":"64","author":"Sredni","year":"2004","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.imbio.2012.07.032_bib0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00008390-200302000-00003","article-title":"Enzyme and integrin expression by high and low metastatic melanoma cell lines","volume":"13","author":"Staquicini","year":"2003","journal-title":"Melanoma Res."},{"issue":"20","key":"10.1016\/j.imbio.2012.07.032_bib0200","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1158\/0008-5472.CAN-08-1242","article-title":"A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule\/MUC18-dependent interaction: evidence from mice and humans","volume":"68","author":"Staquicini","year":"2008","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.imbio.2012.07.032_bib0205","first-page":"6784","article-title":"Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10","volume":"63","author":"Stassi","year":"2003","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.imbio.2012.07.032_bib0210","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1172\/JCI31405","article-title":"Immune surveillance of tumors","volume":"117","author":"Swann","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.imbio.2012.07.032_bib0215","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/eji.200940288","article-title":"Macrophage polarization to a unique phenotype driven by B cells","volume":"40","author":"Wong","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2012.07.032_bib0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nri1995","article-title":"Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment","volume":"7","author":"Yu","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.imbio.2012.07.032_bib0225","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat. Rev. Immunol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298512001969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298512001969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:36:48Z","timestamp":1759250208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298512001969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0171298512001969"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2012.07.032","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B16 melanoma cells increase B-1 cell survival, IL-10 production and radioresistance in vitro","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2012.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}